Ray Amrit bought RARE
May 14, 2026 · Form 4 insider transaction
Ray Amrit bought 7,751 shares of Ultragenyx Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,751
Price
$0.00
Total value
N/A
InsiderRay Amrit
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 14, 2026
Filing dateMay 18, 2026
Shares owned after31,116
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027.